Echinacea purpurea aerial extract alters course of influenza infection in mice

Vaccine. 2010 May 21;28(23):3956-62. doi: 10.1016/j.vaccine.2010.03.047. Epub 2010 Apr 9.

Abstract

Influenza infection is a major clinical problem and Echinacea purpurea, a widely consumed botanical product, is purported to alter the course of respiratory infections including influenza. Mice infected with WSN influenza A and treated with E. purpurea polysaccharide extract had less weight loss than untreated mice but similar pulmonary viral titers. Echinacea-treated mice had lower systemic and pulmonary KC and IL-10 levels and lower systemic IFN-gamma levels following influenza infection. These suggest that E. purpurea alters the clinical course of influenza infection in mice through modulation of cytokines and not direct antiviral activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Weight
  • Cytokines / immunology
  • Echinacea / chemistry*
  • Female
  • Influenza A Virus, H1N1 Subtype
  • Interleukin-10 / immunology
  • Lung / virology
  • Mice
  • Mice, Inbred C57BL
  • Orthomyxoviridae Infections / drug therapy*
  • Phytotherapy*
  • Plant Components, Aerial / chemistry
  • Plant Extracts / therapeutic use*
  • Polysaccharides / therapeutic use
  • Viral Load

Substances

  • Cytokines
  • Plant Extracts
  • Polysaccharides
  • Interleukin-10